首页> 外国专利> METHOD FOR EVALUATING SIDE-EFFECT ONSET RISK IN ANTICANCER DRUG TREATMENT, INCLUDING DETECTING MUC4 GENE POLYMORPHISM

METHOD FOR EVALUATING SIDE-EFFECT ONSET RISK IN ANTICANCER DRUG TREATMENT, INCLUDING DETECTING MUC4 GENE POLYMORPHISM

机译:评估抗癌药治疗中副作用效应的方法,包括检测MUC4基因多态性

摘要

It is designed to provide a kind of evaluation kit risk evaluating method and evaluation paresthesia epilepsy diffuse alveolar injury, since these factors are as administration with anticancer agents. The object of the invention, which also resides in, provides a kind for the treatment of of the side effect of anticancer agent for assessing occurrence risk. The diffuse alveolar injury of appraisal procedure and assessment risk assessment external member breaking-out, it is present in the side effect in a kind of anti-cancer agent therapy for evaluating occurrence risk of MUC4 science of heredity including detection gene pleiomorphism, the patient for being present in MUC4 genes including detection gene pleiomorphism is scheduled for administration with anticancer agents.
机译:由于这些因素与抗癌药一起给药,因此它旨在提供一种评估试剂盒风险评估方法和感觉异常性癫痫弥漫性肺泡损伤评估。本发明的目的还在于,提供一种用于治疗抗癌药的副作用以评估发生风险的方法。弥漫性肺泡损伤的评估程序和评估风险评估外部成员的爆发,它存在于一种抗癌药物治疗中,用于评估包括检测基因多态性在内的MUC4遗传学的发生风险,患者存在于包括检测基因多态性在内的MUC4基因中的SNP计划与抗癌药一起给药。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号